The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.-Reference-Cited by-同舟云学术

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Published:2012-11 Issue:43 Volume:16 Page:
ISSN:1366-5278
Container-title:Health Technology Assessment
language:en
Short-container-title:Health Technol Assess

Author:

Cherry MG¹,Greenhalgh J,Osipenko L,Venkatachalam M,Boland A,Dundar Y,Marsh K,Dickson R,Rees DC

Affiliation:

1. Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK

Funder

Health Technology Assessment programme

Publisher

National Institute for Health Research

Subject

Health Policy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCD Screening and Spending Among Children With Sickle Cell Anemia;The American Journal of Managed Care;2023-03-20

2. Updating the role of transcranial Doppler in prediction and prevention of stroke in correlation to the regularity of blood transfusion in Egyptian children with sickle cell anemia;Egyptian Journal of Radiology and Nuclear Medicine;2022-12-14

3. Stroke in sickle cell disease and the promise of recent disease modifying agents;Journal of the Neurological Sciences;2022-11

4. The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting;Journal of Comparative Effectiveness Research;2022-09

5. Accuracy of transcranial Doppler in detecting intracranial stenosis in patients with sickle cell anemia when compared to magnetic resonance angiography;Journal of Clinical Ultrasound;2022-03-04